FGF21 and metabolic syndrome: Data in Table 1 display an increasing trend of FGF-21 levels (although not significant) when comparing patients with increased WC vs normal WC (NCEP-ATPIII criterion cut-off for WC), those affected by MetS vs patients without MetS, diabetic vs non diabetic, and patients with atherosclerosis vs patients without it.